Owner's reply Hi Bev, thank you very much for your wonderful review
The researchers said this reduction in AFib risk remained consistent, regardless of the level of weight change
Common side effects include nausea, vomiting, and diarrhea, but more severe complications, such as gastroparesis and gallbladder disease, have also been reported
[5] [10] It works by mimicking the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
However, early findings suggest that GLP-1 receptor agonists may actually have some protective effects in the gut
Upcoming CVD outcome trials, such as the EXSCEL study of exenatide weekly, the LEADER study of liraglutide and the REWIND study of dulaglutide might provide further insight in this matter (Table 1)